The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects
Author:
Affiliation:
1. Chengdu Anticancer Bioscience, Ltd., and J. Michael Bishop Institute of Cancer Research, Chengdu 610000, China
2. Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610000, China
Funder
Anticancer Bioscience, Ltd
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.1c00429
Reference39 articles.
1. Paclitaxel: What has been done and the challenges remain ahead
2. Microtubule-binding agents: a dynamic field of cancer therapeutics
3. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
4. How Do Microtubule-Targeted Drugs Work? An Overview
5. A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell Killing;Cancers;2024-05-25
2. Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09
3. Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases;Current Medicinal Chemistry;2023-05-03
4. Characterization of mitotic phenotypes associated with a MYC synthetic lethal compound;2023-04-05
5. Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B;Bioorganic & Medicinal Chemistry;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3